Antimony(Sb)-yeast mannan complexes were synthesized as a strategy to introduce Sb into macrophages infected with Leishmania amastigotes. The complexes were taken up by endocytosis after specific recognition by a-D-mannosyl receptors on the macrophage membrane. About 90 0% of the intracellular parasites were destroyed by Sb-mannan in vitro, whereas the corresponding Sb concentration used as the pentavalent antimonial drug glucantime destroyed about 60% O of the amastigotes.
INTRODUCTION
Leishmaniasis is a parasitic disease affecting 12 million people in the world (Modabber, 1987) . Treatment has been achieved with antimonials, amphotericin B and pentamidine, which, however, can cause severe toxic effects. Toxicity occurs probably because these drugs, at the concentrations used, affect host cells other than the macrophages harbouring the parasites. Liposome inclusion of clinically useful drugs has been more effective than free drugs for treatment of experimental leishmaniasis (Black et al., 1977; Alving et al., 1978; New et al., 1978 New et al., , 1981 , but this method has limitations. Selective destruction of intracellular amastigotes of Leishmania (L) amazonensis by lysosomotropic amino acid esters, which presumably enter macrophages by passive diffusion, has also been described (Rabinovitch et al., 1986; Alfieri et al., 1989) .
The effective intracellular killing of parasites by selective drug delivery to macrophages based on the specificity and high efficiency of receptor-mediated endocytosis has been attempted. The leishmanicidal drug is coupled to a carrier substance which is recognized by macrophage receptors Chaudhuri et al., 1989; Chakraborty et al., 1990) . In the present investigation, the leishmanicidal effects of antimony (Sb) complexes of yeast mannan and mannan derivatives were compared with those of glucantime, a pentavalent antimonial drug currently used in the chemotherapy of leishmaniasis. a-D-Mannosyl-binding receptors are well characterized in macrophages (Stahl et al., 1980; Stahl & Gordon, 1982) . We therefore hypothesize that these receptors could mediate binding and accumulation of soluble Sb-mannan and Sb-mannan derivatives inside Leishmania-bearing macrophages, thus contributing for clearance of the parasitic infection.
MATERIALS AND METHODS
Preparation of yeast mannan Yeast mannan was prepared as previously described (Gorin and Spencer, 1970) by extraction of baker's yeast with hot 2 % KOH None of the Sb complexes prepared with mannan acid or basic derivatives was as effective as the simple Sb-mannan complex in clearing macrophage infection by Leishmania (L) amazonensis. The leishmanicidal effect of Sb-mannan was also demonstrated in vivo with infected hamsters. The alternative use of Sbmannan complex in the treatment of human leishmaniasis is envisaged on the basis of parasite-killing efficiency and the use of a low antimony dose.
followed by treatment of liberated polysaccharide with Fehling solution, which precipitated mannan as its Cu complex. After deionization, the polysaccharide was recovered and precipitated in methanol, yielding 2.2%o mannan (based on wet weight of yeast).
Preparation of CM-(carboxymethyl)mannan
The method of Karabinos and Hindert (1954) was used. Mannan (5 g) in 30%h NaOH (13.3 ml) with propan-2-ol (16 ml) was treated, dropwise with stirring, with a solution of monochloroacetic acid (6 g) in a little propan-2-ol. The temperature was then raised to 55°C, and after a given time (see below), the soluble material was decanted and added to methanol containing 30% of water (170 ml). Sufficient acetic acid was added to neutralize the excess alkali and the precipitate was filtered off, washed with ethanol and dried. Various preparations were carried out, maintaining the temperature at 55°C for different times. The degree of substitution (DS; mol of substituent/mol of anhydromannose unit) was determined by methods involving conversion of the copper salt into CuO (McLaughlin and Herbst, 1950) , conversion of the sodium component of CM-mannan to NaCl, acid washing (Eyler et al., 1947) or treatment with resin, followed by titration, conversion into the uranyl derivative and thence into U308 (Francis, 1953 (Dodgson and Price, 1962) or gravimetrically, or treated with resin followed by acid titration. By using a variety of molar proportions of the chlorosulphonic reagent (mol/mol of anhydromannose in parentheses) the DS values were: 0.29 (0.45), 0.4 (0.62), 0.65 (1.25), 1.29 (1.87) and 1.65 (2.5).
Mannan phosphates
As described by Paschall (1964) , NaH2PO4,H20 (2.8 g; 2 mol/ mol) and Na2HPO4,7H20 (4.18 g; 2 mol/mol) were dissolved in water (15.9 ml), final pH 6.1 at 35°C. Mannan (5 g) was dissolved, the solution evaporated, and the residue left at 100°C for 15 h and then for 1, 2, 3 and 5 h at 155 'C. The product was dissolved in water, dialysed and freeze-dried. The yield was 5.64 g after incubation for 4 h. The DS values were determined spectrophotometrically using sulphomolybdate and molybdovanadate (Chen et al., 1956 ) and by treatment with cationic ionexchange resin followed by titration. The DS values thus obtained were 0.06 (1 h), 0.1 (2 h), 0.16 (3 h) and 0.25 (5 h).
DEAE-mannan
By using the method of Bullock and Guthrie (1965) , to a solution of mannan (5 g) and NaOH (3.3 g) in water (17.4 g), 2-chlorotriethylamine hydrochloride (2.9 g) in water (25 ml) was added dropwise, the temperature being maintained at 0 'C. The solution was kept at 85 'C for 1, 2, 3, 4 and 6 h in separate experiments, and the solutions were then dialysed and freeze-dried. The yield was 5.46 g in the one that was incubated for 4 h. The DS values were determined by treatment with strongly basic ion-exchange resin and titration of the product. They were: 0.11 (1 h), 0.13 (2 h), 0.19 (3 h), 0.24 (4 h), 0.32 (5 h) and 0.32 (15 h).
Complexation of mannan and mannan derivatives with Sb Polysaccharide (1 g) in water (50 ml) at 0°C was treated with stirring with various proportions of SbCl5 (0.78, 1.1, 1.56 and 2.34 mol/mol of anhydromannose) for 15 min and the solution then adjusted to pH 7.0 with aq. 100% (w/v) NaHCO3, and heated at 60°C for 1 h. Insoluble material was removed and the supernatant treated with methanol to a concentration of 70 %. The precipitate was then isolated. In another process, the solution was dialysed instead of being treated with methanol.
Estimation of Sb content in complexes
Two different methods were used. (a) The sample was acidified with H2SO4 and a solution of KI and 25 % H2SO4 added.
Absorbance was measured at 425 nm using a blank and a standard of potassium antimony tartrate (Vogel, 1981a) . (b) The sample was acidified with concentrated HCI to 4 M, aq. 100 tartaric acid was added with KI and, after 5 min, the solution was titrated with 0.1 M Na2S203 (Vogel, 198 lb) . The Sb contents of the various preparations are summarized in Table 1. '3C-n.m.r. spectroscopy Solutions of substituted mannans in 2H20 were examined at 70 'C. Chemical shifts (8) are expressed in p.p.m. relative to tetramethylsilane (= 0) determined in a separated experiment.
Leishmania cells
Amastigotes of Leishmania amazonensis were transferred every 4-6 weeks to golden hamsters by inoculation into the footpads. Amastigote suspensions were prepared by homogenization of the excised lesions. The infiltrated tissue was homogenized in RPMI 1640 containing 10 % fetal calf serum (FCS), and a suspension of amastigotes was obtained after cell disruption by four passages through 22-gauge needles and centrifugation at 2510 g for 10 min. The supernatant fluid was centrifuged at 1400 g for 10 min and the pellet resuspended in RPMI with 10 % FCS.
Macrophage cultures Macrophages were collected in phosphate-buffered saline (PBS) from the peritoneal cavities of mice. About 4 x 105 cells were allowed to attach to round 12 mm-diameter cover-glasses. These were rinsed with PBS and placed in 16 mm-diameter wells of Costar plates containing 0.5 ml of RPMI with 10 % heatinactivated FCS, 100 units/ml penicillin and 100 ,ug/ml streptomycin, and incubated in an atmosphere of air/CO2 (19:1) at 37 'C. After 24 h, the macrophage cultures were infected with the parasites in a proportion of three amastigotes per cell. Infected macrophages were used in the experiments with Sb-mannan 48 h after infection. Most (98 %) macrophages were infected, showing large parasitophorous vacuoles harbouring amastigotes, a typical feature of the infection by species from the Leishmania mexicana taxonomic complex.
Sb-mannan solutions for endocytosis experiments
Solutions of the Sb-mannan complexes were prepared in PBS by overnight incubation at 37 'C followed by centrifugation at 450 g for 5 min. The supernatant fluids were adjusted to pH 7-7.2, sterilized by filtration (Costar LB filter; 0.45,um pore size) and the final concentration of polysaccharide was estimated by sugar colorimetric assay (Dubois et al., 1956 ).
Treatment with Sb-mannan of hamsters infected with L amazonensis Hamsters (4 to 8 weeks old, weight 125 to 150 g) were infected in their footpads with 2 x 106 L. amazonensis amastigotes isolated from donor-hamster footpads as described above. After 6 weeks the hamsters were inoculated subcutaneously near each footpad lesion with Sb-mannan (containing 19.5 ,ug of Sb) on days 1-5 (total of 390 ,ug of Sb/hamster). Control animals received mannan at the same concentration used for Sb-mannan (48 mg, total), as well as glucantime (from a commercial source; 0.3 g/ml) at a dose effective in destroying 99°parasites in hamsters (3.27 mg/day per footpad) during 5 days (65.4 mg total). Two hamsters were used for each drug. Animals were also inoculated intraperitoneally using the same final drug concentration. (Turvey, 1965) . Such derivatives have an i.r. absorption band at 1240 cm-' (Lloyd, 1962 ) that was also observed in the spectrum of the mannan. '3C-n.m.r. studies on the sulphation of methyl 3-0-methyl ac-D-mannopyranoside at OH-6 showed that the C-5 signal suffered a ,-shift of -2.0 p.p.m. (Honda et al., 1973) . Such a shift occurred with the C-5 signal of the mannan originally at 8 74.8.
Additional signals were detected in the 13C-n.m.r. spectrum of DEAE-mannan at 8 100.7 (C-I of non-reducing end and adjacent 3-0-substituted units, suffering a f-shift of -3.0 p.p.m. from 8 103.7) due to substitution at OH-2, and 8 73.8. (3l-shift of -1.2 p.p.m. of C-5 signal originally at 75 p.p.m.), due to substitution at OH-6.
In the case of phosphorylation, an additional signal at 8 64.4 arose, due to phosphorylation at OH-6 (a-shift of 1.7 p.p.m.; see Gorin 1973a) .
Antimony complexes of mannan and its derivatives were prepared starting with various proportions of Sb2o, as reagent.
Final isolation was effected by methanol precipitation or by dialysis. The final products, although originally soluble in water, could not be completely redissolved.
Leishmanicidal effect of Sb-mannan in vitro
Mouse peritoneal macrophages were infected with L. amazonensis amastigotes for 48 h as described above and treated with different Sb-mannan concentrations. Infected macrophages used as controls were treated with PBS, mannan and glucantime. Figure 1(a) shows the infected macrophages at the start of the Sb-mannan treatment. Very large parasitophorous vacuoles were seen harbouring many amastigotes. Figure 1(b) shows infected macrophages after 3 days of treatment with 500,ug/ml of Sb-mannan (6.6,ug/ml of Sb). After this period the large parasitophorous vacuoles and their amastigotes disappeared and the macrophages recovered their normal morphology. The cell viability was followed by Trypan Blue exclusion.
The kinetics of L. amazonensis amastigote destruction in infected macrophages treated with different Sb-mannan concentrations is shown in Figure 2 (500 /ag/ml); *, Sb-mannan and mannan (1 mg/ml). 'Phagocytic index' is defined in Figure   2 .
in the same period. The relative effectiveness of the mannan derivative complexes at 2 mg/ml and little difference in Sb content (Table 1) was: Sb-mannan phosphate = Sb-CMmannan > Sb-mannan sulphate. The DEAE-mannan complex was even more effective than Sb-mannan at 1 mg/ml, but caused morphological alterations or destroyed the macrophages at 2-5 mg/ml. Samples were prepared with 0.78 mol of SbCl5/mol of anhydromannose.
To test whether the Sb-mannan uptake by macrophages is dependent on an c-mannosyl receptor, a competition experiment with mannan or mannose was performed. The results clearly showed that, on increasing the mannan concentration, there was a proportional decrease in the intracellular parasite destruction caused by the Sb-mannan complex (Figure 3 ). Similar results were obtained when the test was carried out with mannose at 1 mg/ml.
Efficacy of Sb-mannan in treating hamsters infected with L. amazonensis
Golden hamsters were infected with L. amazonensis amastigotes and the subcutaneous treatment with Sb-mannan was started 45 days afterwards as described above. There was a significant size reduction of the footpad lesions in hamsters treated with Sbmannan (Table 2) , similar to the reduction observed in animals treated with glucantime (80 % reduction in relation to untreated or mannan-treated controls). In this protocol the final antimony concentration administered for Sb-mannan and for glucantime was 390 ,ug/hamster and 65.4 mg/hamster respectively. Intraperitoneal drug administration did not reduce the footpad lesions either with Sb-mannan or glucantime.
DISCUSSION
Among antimonial drugs currently utilized in the treatment of leishmaniasis, the one of preference in Brazil is the antimonate of N-methylglucamine (1-deoxy-I -methylamino-D-glucitol) or glucantime, whereas in other countries, particularly Frenchspeaking ones, sodium stibogluconate (Pentostan) is the preferred drug. The basic and acid nature of these drugs possibly give rise to complexes which are more stable than those in simple polyhydroxylic systems. We therefore prepared basic and acid derivatives of yeast mannan as a step toward obtaining stable Sb complexes.
The value for the DS chosen for the DEAE-, CM-, phosphate and sulphate derivatives of mannan was 0.25 mol/mol of anhydromannose unit. Presumably, at this level, sufficient hydroxy groups would remain free to form antimony complexes, and a high proportion of mannopyranosyl groups would remain capable of binding to macrophages. These complexes were then compared with the simple Sb-mannan complex for their biological activity.
Little is known about the mechanism of complexation of Sb with polyhydroxy systems but, by analogy with the formation of (Boeseken, 1949) , it could react with 4,6-and 2,3-dihydroxy groups of mannopyranosyl units (structures I and II): Contrary to what might be predicted, the Sb complexation with unsubstituted mannan was more stable than that with the mannan derivatives, as inferred from dialysed preparations of the Sb-complexes (Table 1) . As compared with Sb-mannan, the Sb contents in the other complexes, after dialysis in water, were on average reduced to one-third of that of the unsubstituted mannan complex. Like the borate complex, that of Sb could be in equilibrium with mannan and antimonate in aqueous solution. Such as dissociation might be prejudicial to the action of the drug, although the possibility exists that the mannan may act as a scavenger for antimonate and that they remain in close proximity, being effective as a target. However, this remained in doubt until the 'in vitro' toxicity experiments were carried out.
As shown in the present study, the Sb-mannan complex at 750 ,ug/ml (6.6 ,tg/ml Sb) was able to destroy approx. 98 % of the parasite burden of macrophages infected with L. amazonensis, with a leishmanicidal activity 3-fold higher than that with glucantime. None of the other Sb complexes of acid and basic derivatives of mannan were as effective, and some were rather toxic to macrophages. That the internalization of Sb-mannan occurs by endocytosis after specific recognition by a-D-mannosyl receptors on the macrophage membrane was shown by mannan/mannose competition experiments. The inhibition of Sb-mannan incorporation by infected macrophages in the presence of increasing mannan or mannose concentrations was inferred from the corresponding reduction of the leishmanicidal effect of the Sb-complex.
The proposed mechanism of action of Sb-mannan involves: (a) macrophage uptake of the complex via recognition by an a-D-mannosyl receptor and endocytosis; (b) fusion of the endocytic vesicle carrying the complex with the parasitophorous vacuole; (c) dissociation of the complex at the acid pH of the parasitophorous vacuole with the formation of toxic Sb205; (d) de- struction of the parasites without affecting macrophage viability. Although this sequence of events may involve additional steps, those suggested are based on previous observations on Leishmania-infected macrophages. Thus, the occurrence of fusion between the parasitophorous vacuoles and secondary lysosomes has been demonstrated by different authors using lysosomotropic drugs (Alexander & Vickerman, 1975; Berman et al., 1981; Brazil, 1984) . The low pH in the phagolysosomal compartment is not measurably altered by Leishmania amastigotes (Chang, 1980) , which have enhanced metabolism at pH 5 (Mukkada et al., 1985) . In addition, we have observed that treatment of Leishmania-infected macrophages with NH4C1, which raises the internal pH of the parasitophorous vacuole, prevents parasite destruction by Sb-mannan (results not shown). This is evidence that an acidic pH is necessary to dissociate the complex releasing Sb (Sb2O5) to perform the leishmanicidal effect. A prior decomposition of the complex is necessary to kill the parasites, since isolated amastigotes are not harmed by Sb-mannan.
The leishmanicidal effect of Sb-mannan could also be demonstrated in infected animals. Our 'in vivo' results showed a significant decrease in the size of the lesions after Sb-mannan treatment, although a complete reduction was not obtained. Also, a relapse was observed 44 days after treatment with either Sb-mannan or glucantime. Certainly, additional efforts will be necessary to optimize the Sb-mannan administration protocol, both in terms of doses and frequency. Our data already show, however, that Sb-mannan is comparable in efficiency to glucantime at Sb concentrations 160 times lower than that in glucantime. Higher Sb-mannan concentrations are still limited by the incomplete solubility of the complex in physiological solutions. The use of smaller mannan fragments as Sb carriers, as well as other solubilization procedures of the complex, could be alternatives to solve this problem.
The efficiency of mannan-coupled antimony in killing Leishmania amastigotes both in vitro and in vivo allows one to envisage the introduction of this complex as an alternative antimonial drug for treatment of human leishmaniasis, with the advantage of using low antimony doses.
